What is SMC International?

SMC International connects international patients with 50+ expert doctors across 8 crucial wellness and investment pages, simplifying global healthcare access.

Can Americans travel to Cuba for diabetic foot treatment?

Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Direct charter flights are available from Miami, Tampa, and Fort Lauderdale.

How does Cuba's diabetic foot wound care compare to U.S. standard care?

The key difference is the availability of Heberprot-P and the intensity of care. In the U.S., patients typically receive weekly wound clinic visits with standard dressings and off-loading. In Cuba, patients receive daily treatment — Heberprot-P injections 3 times per week, daily debridement, infection management, and coordinated multidisciplinary care — in a concentrated 2–4 week program.

Can Cuba help avoid diabetic foot amputation?

Cuba's program focuses on wound healing and limb preservation. Heberprot-P, combined with comprehensive wound care, infection management, and vascular assessment, aims to heal chronic ulcers. However, no treatment can guarantee amputation prevention in all cases. Our multidisciplinary team evaluates each patient individually to determine whether the program may be appropriate for their specific circumstances. Outcomes depend on wound severity, vascular status, infection control, and overall health.

Does U.S. health insurance or Medicare cover diabetic foot treatment in Cuba?

No. Medicare, Medicaid, and U.S. private health insurance typically do not cover treatment in Cuba. Patients are responsible for the full cost. However, HSA/FSA funds may be usable for qualified medical expenses abroad — consult your plan administrator. Medical expenses may also be tax-deductible if they exceed 7.5% of adjusted gross income. The secure payment gateway accepts U.S. credit cards (Visa, MasterCard, Amex).

How long is the diabetic foot treatment program in Cuba?

Programs typically last 2–4 weeks depending on the severity of the ulcer, the presence of infection, and the patient's overall health. The duration is determined by the multidisciplinary medical team following the initial evaluation. Some patients with complex or multiple ulcers may require longer programs.

What is the diabetic foot rehabilitation program in Cuba?

After a diabetic foot ulcer heals, rehabilitation is essential to restore mobility and prevent recurrence. Cuba's rehabilitation program includes gait training, orthotic assessment and fitting, physical therapy, vascular and neurological monitoring, and comprehensive diabetic foot-care education. Up to 40% of healed diabetic foot ulcers recur within one year without proper prevention — rehabilitation addresses this risk.

How quickly will we see wound healing during the intensive program?

Wound healing is a gradual process. During the 2–4 week intensive program, the team monitors wound size, depth, granulation tissue formation, and signs of infection reduction. Some patients see measurable wound size reduction within the first 1–2 weeks. Complete healing may continue after returning home, supported by the personalized continuation plan and telemedicine follow-up. The rate of healing depends on vascular status, infection control, and off-loading compliance.

What happens if the wound doesn't heal during the program?

Every patient is individually evaluated before acceptance. If the multidisciplinary team determines during the initial assessment that the wound is unlikely to benefit from the program — for example, in cases of severe vascular insufficiency without revascularization options, or extensive tissue necrosis — they will communicate this honestly. The team may recommend vascular intervention first, or alternative supportive care. Transparency about expected benefit is a core principle of the Cuban program.

How long is the intensive diabetic foot treatment program in Cuba?

The standard intensive program runs 2–4 weeks, depending on wound severity, infection status, and healing progress. Each week includes 5 days of treatment, with daily wound care and Heberprot-P injections 3 times per week. The duration is determined by the medical team following the initial in-person evaluation. Patients with complex or multiple ulcers may require longer programs.

What is the recovery timeline after returning home from Cuba?

The patient returns home with a comprehensive medical report and a personalized foot-care continuation plan. Wound healing may continue after return, supported by the home-care plan and coordination with the U.S. podiatrist. Scheduled telemedicine follow-ups with the Cuban team help monitor progress. Once the wound is fully healed, the rehabilitation phase begins — gait training, orthotic fitting, and foot-care education to prevent recurrence.

How often do patients need follow-up after returning to the U.S.?

Telemedicine follow-ups are typically scheduled at 1, 3, and 6 months after returning home. The Cuban team monitors wound healing progress, adjusts the home-care plan, and coordinates with the patient's U.S. podiatrist and endocrinologist. Some patients may return for a second intensive program if they have multiple ulcers or complex wounds requiring additional treatment cycles. There is no mandatory return schedule.

How long does the medical review take before we can travel to Cuba?

After submitting medical records (wound photos, measurements, vascular studies, blood work, and medication list), the wound-care team reviews them and responds with a treatment proposal within 5–10 business days. If the proposal is accepted, travel coordination — including travel authorization documentation, flight booking, and accommodation — typically takes an additional 2–3 weeks. Most families complete the process within 4–6 weeks.

Who is eligible for the diabetic foot wound-care program in Cuba?

Eligibility is determined through individual medical review. The program most commonly accepts patients with Wagner grade 1–3 diabetic foot ulcers that have not healed after 4+ weeks of standard wound care. Patients must be medically stable enough to travel and participate in daily treatment. The multidisciplinary team reviews each case individually — acceptance is based on wound severity, vascular status, infection control, and overall health, not on a fixed checklist.

Is there a wound condition that is too severe for the Cuban program?

Yes. Patients with Wagner grade 4–5 ulcers (extensive tissue necrosis or gangrene), severe vascular insufficiency without revascularization options, or unstable systemic infection may not be suitable for the program. The team evaluates wound severity, vascular status, infection control, and overall health during the medical review. If the team determines the program would not provide meaningful benefit, they communicate this honestly. This is why the pre-travel medical review is essential.

What medical records are required for the eligibility evaluation?

The medical review requires: (1) wound photographs (multiple angles, with a measurement reference), (2) wound measurements (length, width, depth), (3) vascular studies (Doppler ultrasound, ankle-brachial index, angiography if available), (4) blood work (CBC, metabolic panel, HbA1c, albumin), (5) current medication list, and (6) a summary of wound history and prior treatments. Additional records may be requested based on the individual case. All records can be submitted securely through our online upload portal.

Does a family member need to accompany the patient?

It is strongly recommended that a family member or caregiver accompany the patient, particularly for patients with mobility limitations. The caregiver receives education in wound care, off-loading techniques, daily foot inspection, and blood sugar management — skills essential for preventing recurrence after returning home. While not always mandatory, caregiver participation significantly improves long-term outcomes and is strongly encouraged.

Can patients with poor circulation or peripheral artery disease participate?

Adequate blood flow is essential for wound healing. Patients with peripheral artery disease (PAD) are evaluated individually — those with mild to moderate vascular impairment may be accepted, while those with severe vascular insufficiency without revascularization options may not be suitable. The team reviews Doppler ultrasound, ankle-brachial index (ABI), and angiography results during the medical review. In some cases, the team may recommend vascular intervention (revascularization) before starting the wound-care program. This is assessed case by case.

Is there an age limit for the diabetic foot limb-preservation program?

There is no fixed age limit. Eligibility is based on medical stability and the ability to participate in daily treatment, not age alone. The team evaluates cardiovascular health, kidney function, infection status, and overall fitness for international travel. Many older patients with well-managed co-existing conditions have participated successfully. Each case is assessed individually during the medical review.

Can a patient who has been told they need amputation still apply for the program?

Yes. Many patients seek Cuba's opinion after amputation has been recommended or scheduled. The team provides an independent assessment of whether limb preservation may still be possible. However, not all cases can be accepted — patients with extensive tissue necrosis (Wagner grade 4–5), gangrene, or severe vascular insufficiency may not be suitable. The pre-travel medical review determines whether the program may offer meaningful benefit. If not, the team communicates this honestly.

What are the success rates for limb preservation in Cuba's diabetic foot program?

Cuba's program aims to promote wound healing and preserve the limb whenever medically feasible. However, we do not publish a single 'success rate' percentage because outcomes depend heavily on individual factors: wound severity (Wagner grade), vascular status, infection control, blood sugar management, nutritional status, off-loading compliance, and overall health. The multidisciplinary team evaluates each patient individually before acceptance and provides an honest assessment of expected benefit. No specific outcome — including amputation prevention — is guaranteed. Individual results vary.

How does the medical team define a successful outcome?

Success is defined individually for each patient based on their starting condition. For some, success is complete wound closure; for others, it is significant wound size reduction, control of infection, avoidance of amputation, or improved mobility after rehabilitation. The team sets realistic, patient-specific goals during the initial evaluation and tracks progress against those goals throughout the program. Transparency about expected benefit is a core principle — the team will not accept a patient if they determine the program is unlikely to help.

What factors most influence whether a diabetic foot ulcer can heal?

The key factors are: (1) adequate blood supply (vascular status) — healing cannot occur without sufficient circulation; (2) infection control — uncontrolled infection impairs healing; (3) wound severity — deeper ulcers (higher Wagner grades) are more challenging; (4) blood sugar management — elevated HbA1c slows healing; (5) nutritional status — protein and albumin levels affect tissue repair; (6) off-loading — reducing pressure on the wound is essential; and (7) patient adherence to the home-care plan. The team assesses all of these during the medical review.

Does Cuba publish clinical outcome data for Heberprot-P?

Heberprot-P has been studied in clinical trials and is registered in approximately 20 countries. Peer-reviewed research on its use in diabetic foot ulcers has been published in international medical journals. However, outcomes from Cuba's international patient program are not published as aggregate success-rate statistics. The medical team can discuss the evidence base and expected outcomes for your specific case during the individual review. We encourage patients to review the published research and discuss it with their U.S. physician.

How do limb-preservation outcomes in Cuba compare to U.S. standard care?

A direct comparison is difficult because the patient populations, treatment protocols, and care intensity differ significantly. Cuba's approach combines Heberprot-P (not available in the U.S.) with daily multidisciplinary wound care, aggressive off-loading, and integrated rehabilitation — a more intensive model than typical U.S. weekly wound-clinic visits. The healing-first philosophy means amputation is considered a last resort. However, no treatment guarantees limb preservation in all cases. The most meaningful comparison is individual: our team evaluates your specific wound, vascular status, and health to determine whether the program may benefit you.

What is the typical timeline from arrival in Cuba to wound closure?

Wound healing is gradual and varies by individual. During the 2–4 week intensive program, patients receive daily treatment and Heberprot-P injections 3 times per week. Some patients see measurable wound size reduction within the first 1–2 weeks. Complete wound closure may occur during the program for smaller ulcers, but larger or deeper ulcers may continue healing after returning home, supported by the personalized continuation plan and telemedicine follow-up. The team provides an individualized healing estimate after the in-person evaluation.

How long does the full recovery including rehabilitation take?

The full recovery has two phases. Phase 1 — the intensive wound-care program in Cuba — typically lasts 2–4 weeks. Phase 2 — rehabilitation and ongoing healing at home — begins once the wound is closed or sufficiently healed. Rehabilitation includes gait training, orthotic fitting, and physical therapy, and may continue for several weeks to months after returning home. The total timeline from program start to restored mobility depends on wound severity, healing rate, and rehabilitation progress. The team provides a personalized timeline estimate after evaluation.

When can patients walk normally again after diabetic foot treatment?

Return to normal walking depends on wound healing progress and off-loading requirements. During the program, off-loading (total contact casting or specialized footwear) restricts weight-bearing to protect the wound. Once the wound is closed and the team approves, patients begin gait training and progressive weight-bearing with orthotic support. Full return to normal walking typically follows the rehabilitation phase, which may take several weeks to months after wound closure. The rehabilitation team provides a personalized mobility plan.

How long before patients can return to work and daily activities?

This depends on the nature of the work and the healing progress. Patients with sedentary jobs may resume work relatively quickly after returning home, with accommodations for off-loading and wound care. Patients with physically demanding jobs may need to wait until the wound is fully healed and rehabilitation is complete. The team provides guidance on activity restrictions and a gradual return-to-activity plan based on the individual's healing progress and job requirements.

Diabetic Foot Ulcer Treatment in Cuba for U.S. Patients | Heberprot-P & Wound Care

Is This Program Right for You?

Who Benefits from Diabetic Foot Treatment in Cuba

Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. If any of these describe your situation, Cuba's program may offer options worth exploring.

Non-Healing Diabetic Foot Ulcers

Ulcers that have not healed after 4+ weeks of standard wound care — the primary indication for Heberprot-P intralesional growth factor therapy.

Chronic Diabetic Wounds

Wounds stuck in a chronic inflammatory state that haven't responded to advanced dressings, off-loading, or standard debridement.

Infected Diabetic Foot Wounds

Infected ulcers requiring comprehensive infection management — wound cultures, targeted antibiotics, and surgical debridement.

Recurrent Foot Ulcers

Patients who have had multiple ulcers that heal and return — requiring rehabilitation and orthotic fitting to prevent recurrence.

Diabetic Neuropathy & Foot Complications

Patients with neuropathy, poor circulation, and structural foot deformities that increase ulcer risk and impair healing.

Patients at Risk of Amputation

Patients facing possible amputation who want to explore limb-preservation options before considering surgery.

Second-Opinion Patients

Patients seeking an independent assessment of their wound, treatment history, and options before committing to a treatment path.

Multidisciplinary Wound-Care Seekers

Patients who want a coordinated team — diabetologist, wound specialist, vascular surgeon, podiatrist, and rehabilitation — in one program.

Diabetic Foot Ulcer Treatment Options

Comprehensive Wound-Care & Limb-Preservation Approach

Cuba's diabetic foot program combines biotechnology research with comprehensive wound care, infection management, vascular assessment, and rehabilitation — a multidisciplinary approach that addresses all factors impairing wound healing simultaneously.

Heberprot-P Intralesional Therapy

Cuba's CIGB-developed recombinant human epidermal growth factor (rEGF), injected directly into the wound bed to stimulate cell proliferation and angiogenesis. Not FDA-approved, not available in the U.S.

Comprehensive Wound Care

Surgical debridement, specialized dressings, off-loading (total contact casting), and moisture-balanced wound management delivered daily by a wound-care specialist.

Infection Management

Wound cultures, targeted antibiotic therapy, surgical debridement of infected tissue, and local antiseptics — coordinated by an infectious disease specialist.

Vascular Assessment

Doppler ultrasound, angiography when indicated, and referral for revascularization if blood flow is inadequate for wound healing.

Diabetic Foot Rehabilitation

Gait training, orthotic fitting, physical therapy, and foot-care education to restore mobility and prevent ulcer recurrence after healing.

Second Opinion Evaluation

Independent review of wound status, treatment history, and imaging by Cuba's multidisciplinary wound-care team — a fresh perspective on your treatment options.

No treatment cures diabetes or guarantees wound healing or amputation prevention in all cases. Cuba's program aims to promote wound healing in chronic ulcers through a comprehensive, multidisciplinary approach. Heberprot-P is investigational and not FDA-approved. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.

Heberprot-P Intralesional Therapy

Cuba's Pioneering Growth Factor for Diabetic Foot Ulcers

Heberprot-P contains recombinant human epidermal growth factor (rEGF), developed by Cuba's Center for Genetic Engineering and Biotechnology (CIGB). It is injected directly into the wound bed of diabetic foot ulcers to stimulate cell proliferation and angiogenesis — the processes impaired in chronic diabetic wounds.

Intralesional injection directly into the wound bed — 3 times per week
Stimulates cell growth, angiogenesis, and granulation tissue formation
Designed for chronic ulcers that haven't responded to standard care (4+ weeks)
Most effective for Wagner grade 1–3 ulcers
Combined with debridement, off-loading, and infection management
Registered in ~20 countries; not FDA-approved, not available in the U.S.

Learn About Heberprot-P Treatment

3×/week

Heberprot-P intralesional injections

U.S. wound clinic visitsWeekly

Cuba treatment frequencyDaily (5 days/week)

Program duration2–4 weeks

Growth factor availabilityCuba only

Non-Healing Diabetic Foot Ulcer

When Standard Care Isn't Enough

A diabetic foot ulcer that has not healed after 4+ weeks of standard wound care is classified as chronic and non-healing. In the U.S., options are limited — advanced dressings, negative pressure therapy, or hyperbaric oxygen (which may not be covered by insurance). Heberprot-P is specifically designed for these chronic wounds.

Learn About Non-Healing Ulcer Treatment

Limb-Preservation Program

A Healing-First Philosophy

Cuba's program is built on a different philosophy: healing first, amputation as last resort. Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate — combining aggressive wound care, infection management, vascular assessment, and Heberprot-P to promote healing before considering surgery.

Learn About Limb Preservation

Diabetic Foot Wound Care Comparison

Cuba's Wound-Care Model vs. U.S. Standard Diabetic Foot Care

The most significant difference is the availability of Heberprot-P and the intensity and coordination of care. Understanding this difference helps American patients make informed decisions.

Aspect	U.S. Standard Care	Cuba's Wound-Care Model
Growth Factor Therapy	Not available (Heberprot-P is not FDA-approved)	Heberprot-P intralesional injections, 3×/week
Treatment Frequency	Weekly wound clinic visits (insurance-limited)	Daily treatment, 5 days per week
Team Coordination	Separate specialists, separate appointments	Single multidisciplinary team, coordinated daily
Program Duration	Ongoing, indefinite — weeks to months	Intensive 2–4 week concentrated program
Off-Loading	Variable — often patient-managed	Total contact casting, professionally managed
Rehabilitation	Limited or separate from wound care	Integrated gait training, orthotics, and education
Amputation Focus	Amputation often presented as next step	Healing-first philosophy; amputation as last resort

Diabetic Foot Treatment Outside the USA — By State

State-by-State Diabetic Foot Treatment Guides

We've prioritized the 10 U.S. states with the highest diabetes prevalence. Each state page includes local diabetes statistics, travel logistics, departure airports, and state-specific context for patients considering diabetic foot treatment in Cuba.

Florida

2.4M with diabetes

Texas

2.0M with diabetes

California

3.5M with diabetes

New York

1.5M with diabetes

Pennsylvania

1.0M with diabetes

Ohio

1.0M with diabetes

Michigan

800K with diabetes

Georgia

1.1M with diabetes

North Carolina

900K with diabetes

Illinois

1.1M with diabetes

Louisiana

640K with diabetes

Maryland

650K with diabetes

Mississippi

340K with diabetes

South Carolina

530K with diabetes

Oklahoma

430K with diabetes

Southeastern United States

7.0M with diabetes

Southern United States

9.0M with diabetes

Eastern United States

18.0M with diabetes

East Coast

12.0M with diabetes

International Diabetic Foot Treatment Program

From U.S. Home to Havana and Back

SMC Salud coordinates every step — from medical record review to travel authorization, intensive wound care, rehabilitation, and telemedicine follow-up after you return home.

01

Submit Medical Records

Send wound photos, ulcer measurements, vascular studies, blood work, and medication list. The wound-care team reviews and responds within 5–10 business days with a treatment proposal.

02

Travel to Havana

Direct charter flights from Miami, Tampa, or Fort Lauderdale. SMC Salud provides travel authorization documentation and airport reception in Havana.

03

Intensive Wound-Care Program

2–4 weeks of daily treatment — Heberprot-P injections, debridement, infection management, off-loading, and rehabilitation — all coordinated by a single multidisciplinary team.

04

Return Home with a Plan

Comprehensive medical report for your U.S. podiatrist, personalized foot-care plan, orthotic recommendations, and ongoing telemedicine follow-up with the Cuban team.

timelineEstimator.eyebrow

Estimate Your Diabetic Foot Treatment Timeline in Cuba

Answer three quick questions to see a personalized timeline covering the medical review, travel coordination, intensive wound care, and telemedicine follow-up phases — so you know what to expect at every step.

timelineEstimator.step1Wound

timelineEstimator.step2

timelineEstimator.step3

What best describes your diabetic foot condition?

Meet the Wound-Care Team

The Specialists Behind Cuba's Diabetic Foot Program

Cuba's diabetic foot limb-preservation program is led by a multidisciplinary team of wound-care specialists, vascular surgeons, and endocrinologists with extensive experience in chronic diabetic wound management.

RL

Dr. Roberto López

Lead Wound-Care & Limb Preservation Specialist

Diabetic Foot Surgery · Wound Management

22+ yearsof clinical experience

Credentials

Specialist in Diabetic Foot Surgery, University of Havana
Lead clinician, National Diabetic Foot Care Program
Member, Cuban Society of Angiology and Vascular Surgery

Clinical Focus

Chronic ulcer managementHeberprot-P therapy protocolsLimb preservation

1,500+

International patients treated

22

Years in diabetic wound care

MP

Dr. Marta Pérez

Vascular Surgeon

Vascular Surgery · Peripheral Artery Disease

18+ yearsof clinical experience

Credentials

Specialist in Vascular Surgery, University of Havana
Senior surgeon, National Institute of Angiology
Expert in lower-limb revascularization assessment

Clinical Focus

Vascular assessmentPeripheral artery diseaseRevascularization coordination

2,400+

Vascular evaluations performed

25+

Peer-reviewed publications

FH

Dr. Fernando Hernández

Endocrinologist — Diabetic Foot Specialist

Endocrinology · Diabetes Management

20+ yearsof clinical experience

Credentials

Specialist in Endocrinology, University of Havana
Coordinator, Diabetes Control & Wound Healing Unit
Member, Cuban Society of Endocrinology

Clinical Focus

Blood sugar optimizationDiabetes complicationsNutritional wound support

2,800+

Diabetes patients managed

20

Years in endocrinology

The full multidisciplinary team also includes podiatrists, infectious disease specialists, orthotists, and rehabilitation therapists. Individual team composition is assigned based on each patient's clinical needs after medical evaluation. Specialist availability is subject to the program schedule.

Request a Consultation View All Specialists

Travel, Cost & Payment for U.S. Patients

What American Patients Need to Know

Travel Authorization

• U.S. citizens can travel to Cuba under approved categories
• SMC Salud provides letter of medical necessity
• Direct charter flights from Miami, Tampa, Fort Lauderdale
• Connecting flights via Mexico, Canada, or Bahamas
• Airport reception and ground transport in Havana

Cost & Insurance

• All-inclusive program (medical care + wound care + accommodation + meals)
• Transparent pricing after medical review
• U.S. insurance & Medicare do not cover Cuba treatment
• HSA/FSA funds may be usable — consult your plan administrator
• Medical expenses may be tax-deductible (over 7.5% AGI)

Payment Methods

• Secure online gateway — U.S. credit cards (Visa, MasterCard, Amex)
• International bank transfers in EUR, GBP, or CAD
• USD bank transfers are not accepted
• Itemized invoices provided for HSA/FSA reimbursement
• Comprehensive medical documentation for tax purposes

Diabetic Foot Treatment Abroad — Frequently Asked Questions

Questions from American Patients

Cuba offers Heberprot-P — a recombinant human epidermal growth factor (rEGF) developed by the Center for Genetic Engineering and Biotechnology (CIGB), injected directly into the wound bed to stimulate healing. It is not FDA-approved and is not available in the United States. Combined with comprehensive wound care, infection management, and vascular assessment, this approach offers a treatment option for chronic, non-healing diabetic foot ulcers.

Diabetic Foot Wound Care — Treatment Expectations, Timelines & Eligibility

What to Expect from Diabetic Foot Wound Care

Detailed answers about treatment expectations, recovery timelines, and eligibility criteria for international patients considering Cuba's intensive diabetic foot wound-care program.

Cuba's program aims to promote wound healing in chronic diabetic foot ulcers that have not responded to standard care — not to cure diabetes. Heberprot-P stimulates the proliferative phase of healing (cell growth, angiogenesis, granulation tissue formation). The degree of improvement depends on wound severity (Wagner grade), vascular status, infection control, blood sugar management, and overall health. Our multidisciplinary team evaluates each patient individually and determines whether the program may be appropriate. No specific outcome is guaranteed; individual results vary.

All eligibility and treatment-expectation information is general in nature. Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. Individual suitability is determined only after a full medical review. No specific outcome is guaranteed.

Eligibility, Limb-Preservation Outcomes & Recovery Times

Am I Eligible? What Are the Outcomes and Recovery Times?

Detailed answers about who qualifies for the limb-preservation program, how success is defined, and the realistic recovery timeline — from arrival in Cuba to returning home and resuming daily life.

Eligibility is determined through individual medical review. The program most commonly accepts patients with Wagner grade 1–3 diabetic foot ulcers — superficial ulcers through deep ulcers with abscess or osteomyelitis — that have not healed after 4+ weeks of standard wound care. Patients must be medically stable enough to travel internationally and participate in daily treatment. The multidisciplinary team reviews wound severity, vascular status, infection control, and overall health for each case. Acceptance is based on individual evaluation, not a fixed checklist.

All eligibility, outcome, and recovery information is general in nature. Our multidisciplinary team evaluates each patient individually and determines whether an international wound-care and limb-preservation program may be appropriate. No specific outcome — including wound healing or amputation prevention — is guaranteed. Individual suitability and results are determined only after a full medical review.

Patient Assessment Form

Start Your Medical Evaluation

Complete this secure assessment to help Cuba's wound-care team understand your condition and determine whether an international treatment program may be appropriate. All information is confidential.

Your Information

Medical History

Condition Details

Upload Records

Review & Submit

Step 1 of 5 — Your Information

Your information is encrypted and confidential. We never share data without consent.

medicalRecordsGuide.freeDownload

medicalRecordsGuide.title

medicalRecordsGuide.subtitle

medicalRecordsGuide.desc

medicalRecordsGuide.instantDownload
medicalRecordsGuide.privacy
medicalRecordsGuide.updates

Ready to Explore Diabetic Foot Treatment in Cuba?

Submit your medical records for a complimentary review by Cuba's wound-care team. Receive a personalized treatment proposal within 5–10 business days — no obligation to travel.

Submit Medical Records for Evaluation Request an International Patient Consultation WhatsApp

Diabetic Foot Ulcer Treatment in CubaHeberprot-P, Wound Care & Limb-Preservation Programs for U.S. Patients

Who Benefits from Diabetic Foot Treatment in Cuba

Non-Healing Diabetic Foot Ulcers

Chronic Diabetic Wounds

Infected Diabetic Foot Wounds

Recurrent Foot Ulcers

Diabetic Neuropathy & Foot Complications

Patients at Risk of Amputation

Second-Opinion Patients

Multidisciplinary Wound-Care Seekers

Comprehensive Wound-Care & Limb-Preservation Approach

Heberprot-P Intralesional Therapy

Comprehensive Wound Care

Infection Management

Vascular Assessment

Diabetic Foot Rehabilitation

Second Opinion Evaluation

Cuba's Pioneering Growth Factor for Diabetic Foot Ulcers

When Standard Care Isn't Enough

A Healing-First Philosophy

Cuba's Wound-Care Model vs. U.S. Standard Diabetic Foot Care

State-by-State Diabetic Foot Treatment Guides

From U.S. Home to Havana and Back

Submit Medical Records

Travel to Havana

Intensive Wound-Care Program

Return Home with a Plan

Estimate Your Diabetic Foot Treatment Timeline in Cuba

What best describes your diabetic foot condition?

The Specialists Behind Cuba's Diabetic Foot Program

Dr. Roberto López

Dr. Marta Pérez

Dr. Fernando Hernández

What American Patients Need to Know

Travel Authorization

Cost & Insurance

Payment Methods

Questions from American Patients

What to Expect from Diabetic Foot Wound Care

Am I Eligible? What Are the Outcomes and Recovery Times?

Start Your Medical Evaluation

Your Information

medicalRecordsGuide.title

Ready to Explore Diabetic Foot Treatment in Cuba?